Anti-GFRA1 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22196; research use only.
Know who made it. See the evidence. Buy through one marketplace.
“Introducing our Anti-GFRA1 Polyclonal Antibody – a powerful tool for your biotech research needs.
This polyclonal antibody is specifically designed to target the GFRA1 protein, a key receptor in the glial cell line-derived neurotrophic factor (GDNF) family. GFRA1 is known to play a crucial role in various biological processes, including cell survival, differentiation, and migration.
Our Anti-GFRA1 Polyclonal Antibody is highly sensitive and specific, making it an ideal choice for detecting and quantifying GFRA1 expression in various sample types. It has been extensively validated for use in Western blotting, immunohistochemistry, and immunofluorescence experiments.
One of the main applications of this antibody is in cancer research, particularly in studying the role of GFRA1 in tumor growth and metastasis. It has also been used in neurological studies to investigate the function of GFRA1 in nerve regeneration and neurodegenerative diseases.
In addition to its use in research, our Anti-GFRA1 Polyclonal Antibody has also been successfully used in clinical settings. It has shown promising results in diagnosing and monitoring certain types of cancers, making it a valuable tool for personalized medicine.
Our Anti-GFRA1 Polyclonal Antibody is produced using advanced recombinant technology, ensuring high purity and quality. It has been rigorously tested to ensure consistency and reliability, giving you accurate and reproducible results every time.
With its wide range of applications and proven effectiveness, our Anti-GFRA1 Polyclonal Antibody is a must-have for any biotech laboratory. Order now and take your research to the next level!”
ProteoGenix catalogue number ARO-A22196. For research use only.
Target: GDNF family receptor alpha-1, GDNF receptor alpha-1, GDNFR-alpha-1, GFR-alpha-1, TGF-beta-related neurotrophic factor receptor 1, Gfra1, Gdnfra, Trnr1; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| GDNF family receptor alpha-1, GDNF receptor alpha-1, GDNFR-alpha-1, GFR-alpha-1, TGF-beta-related neurotrophic factor receptor 1, Gfra1, Gdnfra, Trnr1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
